Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
SVRA Savara
- 3.230
- 0.0000.00%
Close Dec 20 16:00 ET
- 3.230
- 0.0000.00%
Post 16:09 ET
554.33MMarket Cap-7.51P/E (TTM)
3.325High3.120Low2.25MVolume3.200Open3.230Pre Close7.27MTurnover2.01%Turnover RatioLossP/E (Static)171.62MShares5.70052wk High2.78P/B361.54MFloat Cap2.81552wk Low--Dividend TTM111.93MShs Float9414.996Historical High--Div YieldTTM6.35%Amplitude0.690Historical Low3.227Avg Price1Lot Size
About Savara Company
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.
Company Profile
SymbolSVRA
Company NameSavara
Listing DateApr 29, 2004
Founded1995
CEOMr. Matthew Pauls, J.D.,M.B.A.
MarketNASDAQ
Employees37
Fiscal Year Ends12-31
AddressOne Summit Square,1717 Langhorne Newtown Road,Suite 300
CityLanghorne
ProvincePennsylvania
CountryUnited States of America
Zip Code19047
Phone1-512-614-1848
Websitehttp://www.savarapharma.com
Company Executives
- Name
- Position
- Salary
- Matthew Pauls, J.D.,M.B.A.
- Chairman of the Board and Chief Executive Officer
- 3.76M
- Robert Lutz
- Chief Operating Officer
- 2.66M
- David L. Lowrance
- Chief Accounting Officer, Chief Financial and Administrative Officer
- 1.52M
- Dr. Raymond Pratt
- Chief Medical Officer
- --
- Anne Erickson
- Chief Business Officer
- --
- Richard J. Hawkins
- Independent Director
- 149.13K
- Nevan Charles Elam, J.D.
- Independent Director
- 157.63K
- David A. Ray
- Independent Director
- 158.13K
- Dr. Joseph S. McCracken, D.V.M.
- Lead Independent Director
- 155.13K
- Dr. An van Es-Johansson, M.D.
- Independent Director
- 155.63K